Literature DB >> 32088365

Improving Quality of Life in Hematopoietic Stem Cell Transplantation Survivors Through a Positive Psychology Intervention.

Hermioni L Amonoo1, Chareeni Kurukulasuriya2, Kate Chilson2, Lynn Onstad2, Jeff C Huffman3, Stephanie J Lee4.   

Abstract

Despite advances in transplantation medicine, psychological distress and quality of life and functional deficits continue to compromise survivorship after hematopoietic stem cell transplantation (HSCT). With increasing numbers of HSCT survivors, supportive oncology interventions that target health-related outcomes in HSCT survivorship are needed. Here we aimed to test the feasibility and acceptability of a group format phone-delivered positive psychology (PP) intervention in HSCT survivors. This is a one-arm pilot study design that adapted and tested an individual PP intervention used in cardiac disease to a phone-delivered group-based program for HSCT survivors who were .4 to 39 years post-transplantation. All participants received an 8-session weekly PP intervention. We assessed feasibility by the enrollment and intervention completion rates. We examined acceptability on a 10-point Likert scale of ease and utility. Unstructured qualitative interviews were used to obtain participant feedback on the intervention for future application in a larger trial. Self-reported assessments on psychological, functional, and quality of life outcomes were administered at baseline and at follow-up (the end of the intervention). Of 64 eligible participants, 29 (45%) enrolled in the study. For the main aim of intervention feasibility and acceptability, participants completed 96% of all PP sessions and rated the ease (7.6 ± 1.7) and utility (8.1 ± 1.1) of sessions highly. Of the self-reported assessments obtained, the PP intervention resulted in improvements in the resilience scale (mean difference, 2.4 ± 5.4; P = .03). From unstructured qualitative interviews, participants reported the PP exercises and intervention helped them to focus on positive emotions and the group format fostered a sense of community and social support. An 8-week phone-delivered group format PP intervention is feasible and acceptable in HSCT survivors. The piloted intervention could be tested with minor modifications in a randomized study to definitively examine the impact of the group format PP intervention on health-related outcomes.
Copyright © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone marrow transplant; Hematopoietic stem cell transplantation; Mood; Positive psychological well being; Positive psychology; Psychological distress; Psychological well-being; Quality of life; Survivorship

Mesh:

Year:  2020        PMID: 32088365     DOI: 10.1016/j.bbmt.2020.02.013

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  4 in total

1.  The Influence of Family-Oriented Enabling Psychological Nursing on Posttraumatic Stress and Fear of Recurrence in Patients with Cervical Cancer.

Authors:  Yue Shi; Zhongye Wu; Hong Wang; Wufan Kong; Xiaowan Zhuansun
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-24       Impact factor: 2.650

2.  Yin and Yang of Psychological Health in the Cancer Experience: Does Positive Psychology Have a Role?

Authors:  Hermioni L Amonoo; Areej El-Jawahri; Emma C Deary; Lara N Traeger; Corey S Cutler; Joseph A Antin; Jeff C Huffman; Stephanie J Lee
Journal:  J Clin Oncol       Date:  2022-04-04       Impact factor: 50.717

3.  Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study.

Authors:  Rahul Banerjee; Chiung-Yu Huang; Lisa Dunn; Jennifer Knoche; Chloe Ryan; Kelly Brassil; Lindsey Jackson; Dhiren Patel; Mimi Lo; Shagun Arora; Sandy W Wong; Jeffrey Wolf; Thomas Martin Iii; Anand Dhruva; Nina Shah
Journal:  JMIR Form Res       Date:  2022-03-04

Review 4.  A Scoping Review on Outcomes and Outcome Measurement Instruments in Rehabilitative Interventions for Patients with Haematological Malignancies Treated with Allogeneic Stem Cell Transplantation.

Authors:  Anastasios I Manettas; Panagiotis Tsaklis; Dario Kohlbrenner; Lidwine B Mokkink
Journal:  Curr Oncol       Date:  2022-07-15       Impact factor: 3.109

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.